Above Baseline — Drug development intelligence, above the noise.

Above Baseline Drug Dev Intel

Latest
My Picks
ADA & Immunogenicity
ADCs
PK/PD
Small Molecule

Uncategorized

Latest in Uncategorized

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

This Week's Digest

01

ADC linker stability in circulation remains the lead challenge this week.

02

FDA ADA guidance comment period — check regulations.gov for deadlines.

03

AAPS NBC 2026 abstract submissions open — check aaps.org.

04

LNP delivery getting renewed attention across mRNA and gene therapy programs.

Browse by Topic

ADA & Immunogenicity ADCs My Picks PK/PD Small Molecule

Pipeline Pulse

NDA submissions YTD 34

ADC programs in Ph I/II 112

FDA RTFs (Q1 2026) 8

Immunogenicity holds 3

© 2026 Above Baseline — Independent drug development news

About Submit / Contact